Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

BSI SA

investment firm

About

BSI SA provides asset management and related services to private and institutional clients in Switzerland and internationally.

Details

Founded date
Jan 1, 1873
Operating Status
Active
Investor Type
Investment Bank

BSI SA provides asset management and related services to private and institutional clients in Switzerland and internationally. The company offers services relating to asset management, including investment funds; placing of fiduciary deposits; and trading in currencies and securities, precious metals, and foreign exchange. Its services include corporate finance services, such as services for mergers and acquisitions, capital markets, and business evaluations; and life insurance solutions as an agent. The company also offers financial planning, advisory, and credit services. As of December 31, 2008, it operated through a network of seven branches in Switzerland; seven representative offices in Athens, Buenos Aires, Hong Kong, Montevideo, Panama, Taipei, and Bahrain; and six banks in Bahamas, Luxembourg, Madrid, Monte Carlo, Paris, and Singapore. The company was founded in 1873 and is headquartered in Lugano, Switzerland. BSI SA operates as a subsidiary of Participatie Maatschappij Graafschap Holland N.V.

Investments

Number of Investments
Number of Lead Investments
5
0
BSI SA has made 5 investments. Their most recent investment was on Jan 10, 2011, when VisionCare Ophthalmic Technologies raised $31M.
Date Company Name
Round Money Raised Industry Lead Investor
Series E $31M Health Care
Jan 19, 2010 GlobeImmune
Series E $17.50M Biotechnology
Sep 30, 2008 Telormedix
Series A $19M Biopharma
Series D $50M Biotechnology
Feb 28, 2005 Perlegen Sciences
Series D $74M Biotechnology

Exits

BSI SA has had 2 exits. BSI SA most notable exits include GlobeImmune ,   Telormedix

Date Company Name Exit Type Industry
Jul 5, 2016 GlobeImmune IPO Biotechnology Detail
Jan 1, 2015 Telormedix M&A Biopharma Detail